Bayer Yaz Patents Are Obvious, Sandoz Tells Fed. Circ.
Sandoz Inc. and two other generic drugmakers told a Federal Circuit panel on Tuesday that a lower court had erred when it affirmed the validity of Bayer Healthcare Pharmaceuticals Inc.'s Yaz...To view the full article, register now.
Already a subscriber? Click here to view full article